| Bioactivity | Atagabalin (PD 0200390) is a selective GABA (gamma-aminobutyric acid) receptor agonist with antianxiety and sedative effects. Atagabalin enhances the activity of the GABA receptor by binding to the α2δ subunit of the GABA receptor, thereby increasing the GABA mediated inhibition. This enhancement results in reduced excitability of neurons, helping to reduce anxiety and improve sleep. Atagabalin can be used to study neuropsychiatric disorders, anxiety or sleep disorders[1]. |
| CAS | 223445-75-8 |
| Formula | C10H19NO2 |
| Molar Mass | 185.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Corrigan B, et al. Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage‐gated calcium channel alpha‐2‐delta subunit[J]. British journal of clinical pharmacology, 2009, 68(2): 174-180. |
Atagabalin
CAS: 223445-75-8 F: C10H19NO2 W: 185.26
Atagabalin (PD 0200390) is a selective GABA (gamma-aminobutyric acid) receptor agonist with antianxiety and sedative eff
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.